Yi Su
Impact in
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Cancer therapeutics and mechanisms 2
- Epigenetics and DNA Methylation 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Jianxun Ding (2 shared papers)Baoyu Gao (1 shared paper)Qian Li (1 shared paper)Yuan Su (1 shared paper)Qinyan Yue (1 shared paper)Xiaodi Li (1 shared paper)Bing Xiong (2 shared papers)Yinghui Wang (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (2 papers)Oncogene (2 papers)Molecular Cancer Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)Alzheimer s & Dementia (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yi Su
24 papers receiving 723 citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 71
- Cancer Research 163
- Molecular Biology 390
- Oncology 139
- Pulmonary and Respiratory Medicine 149
Countries citing papers authored by Yi Su
This map shows the geographic impact of Yi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Su more than expected).
Fields of papers citing papers by Yi Su
This network shows the impact of papers produced by Yi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Su. The network helps show where Yi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 201 | |
| 2 | 2015 | 114 | |
| 3 | 2016 | 72 | |
| 4 | 2018 | 53 | |
| 5 | 1996 | 53 | |
| 6 | 2019 | 48 | |
| 7 | 2018 | 41 | |
| 8 | 2017 | 27 | |
| 9 | 2017 | 26 | |
| 10 | 2019 | 25 | |
| 11 | 2018 | 19 | |
| 12 | 2023 | 7 | |
| 13 | miR-330 regulates interleukin-13-induced MUC5AC secretion by targeting Munc18b in human bronchial epithelial cells. | 2018 | 7 |
| 14 | 2019 | 7 | |
| 15 | 2016 | 6 | |
| 16 | 2025 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2018 | 4 | |
| 19 | 2025 | 2 | |
| 20 | 2020 | 2 |
About Yi Su
Yi Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 30 papers that have together received 728 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Circular RNAs in diseases (2 papers), Cancer therapeutics and mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Molecular Medicine (71 citations), Cancer Research (163 citations), Molecular Biology (390 citations), Oncology (139 citations) and Pulmonary and Respiratory Medicine (149 citations). Yi Su has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jianxun Ding, Baoyu Gao, Qian Li, Yuan Su, Qinyan Yue, Xiaodi Li, Bing Xiong, Yinghui Wang, James Chih‐Hsin Yang and Yu Chen. Their work appears in journals such as European Journal of Medicinal Chemistry, Oncogene, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.